Literature DB >> 25280460

Ribosomal protein P2 localizes to the parasite zoite-surface and is a target for invasion inhibitory antibodies in Toxoplasma gondii and Plasmodium falciparum.

Rajagopal Sudarsan1, Reshma Korde Chopra2, Mudassar Ali Khan2, Shobhona Sharma2.   

Abstract

In the malarial parasite Plasmodium falciparum, the conserved ribosomal stalk protein P2 (PfP2) exhibits extra-ribosomal stage-specific oligomerization and trafficking to the host red cell membrane. Antibodies directed against PfP2 arrested cell division. We sought to examine whether P2 from a closely related Apicomplexan parasite, Toxoplasma gondii, exhibits similar properties in terms of its oligomeric status as well as such unique host-cell localization. Circular dichroism spectroscopy of recombinant P2 from T. gondii (TgP2) showed a structure similar to that of PfP2, but unlike PfP2, which forms SDS- and DTT-resistant oligomers, TgP2 exhibited only a weak SDS-resistant dimerization. Also, unlike PfP2 localization to the infected erythrocyte surface, TgP2 did not localize to the host membrane in T. gondii infected human foreskin fibroblast cells. However, P2 protein was detected on the free tachyzoite surface, corroborated by localization of epitope-tagged P2 transfected in T. gondii. The presence of P2 on the surface of P. falciparum merozoites was also observed, and specific antibodies raised against the P2 protein blocked both T. gondii and P. falciparum zoite invasion of the host cells. Thus, although certain moonlighting functions of the acidic ribosomal protein P2 are different amongst P. falciparum and T. gondii, the P2 protein localizes to the surface of the invasive zoite form, and appears to constitute a potential target for host cell invasion inhibition in both the Apicomplexan infections.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Host invasion; Moonlighting; Non-classical secretion; Plasmodium; Ribosomal protein; Toxoplasma

Mesh:

Substances:

Year:  2014        PMID: 25280460     DOI: 10.1016/j.parint.2014.08.006

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  6 in total

1.  Non-ribosomal insights into ribosomal P2 protein in Plasmodium falciparum-infected erythrocytes.

Authors:  Sudipta Das; Bhaskar Roy; Saswata Chakrabarty
Journal:  Microbiologyopen       Date:  2021-08       Impact factor: 3.139

2.  Expression, tissue localization and serodiagnostic potential of Taenia multiceps acidic ribosomal protein P2.

Authors:  Xing Huang; Lin Chen; Yingdong Yang; Xiaobin Gu; Yu Wang; Weimin Lai; Xuerong Peng; Guangyou Yang
Journal:  Parasit Vectors       Date:  2015-12-01       Impact factor: 3.876

3.  Genome-wide analysis of gene expression and protein secretion of Babesia canis during virulent infection identifies potential pathogenicity factors.

Authors:  Ramon M Eichenberger; Chandra Ramakrishnan; Giancarlo Russo; Peter Deplazes; Adrian B Hehl
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

4.  Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)2 of Plasmodium falciparum in a Mouse Model.

Authors:  Agnieszka Szuster-Ciesielska; Leszek Wawiórka; Dawid Krokowski; Nikodem Grankowski; Łukasz Jarosz; Urszula Lisiecka; Marek Tchórzewski
Journal:  J Immunol Res       Date:  2019-09-12       Impact factor: 4.818

5.  Identification and Characterization of P0 Protein as a Vaccine Candidate Against Babesia divergens, Blood Parasite of Veterinary and Zoonotic Importance.

Authors:  Shimaa Abd El-Salam El-Sayed; Mohamed Abdo Rizk; Haitham Eldoumani; Shimaa Sobhy Sorour; Mohamad Alaa Terkawi; Mahmoud AbouLaila; Ikuo Igarashi; Mohamed Z Sayed-Ahmed
Journal:  Front Vet Sci       Date:  2022-01-07

6.  Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis.

Authors:  ZhengQing Yu; Ke He; WanDi Cao; Muhammad Tahir Aleem; RuoFeng Yan; LiXin Xu; XiaoKai Song; XiangRui Li
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.